tradingkey.logo

Progyny Inc

PGNY
View Detailed Chart
21.950USD
+0.030+0.14%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.89BMarket Cap
33.63P/E TTM

Progyny Inc

21.950
+0.030+0.14%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.14%

5 Days

-8.04%

1 Month

-17.70%

6 Months

-6.56%

Year to Date

-14.52%

1 Year

+0.55%

View Detailed Chart

TradingKey Stock Score of Progyny Inc

Currency: USD Updated: 2026-02-06

Key Insights

Progyny Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 20 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.18.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Progyny Inc's Score

Industry at a Glance

Industry Ranking
20 / 75
Overall Ranking
104 / 4521
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Progyny Inc Highlights

StrengthsRisks
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 48.33% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.17B.
Undervalued
The company’s latest PE is 33.63, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 90.10M shares, decreasing 24.88% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.51K shares of this stock.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
30.182
Target Price
+37.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Progyny Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Progyny Inc Info

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Ticker SymbolPGNY
CompanyProgyny Inc
CEOAnevski (Peter)
Websitehttps://www.progyny.com/
KeyAI